Gilead Sciences, Inc. (GILD)
151.12
-1.62
(-1.06%)
USD |
NASDAQ |
Feb 19, 16:00
150.80
-0.32
(-0.21%)
After-Hours: 04:51
Gilead Sciences Free Cash Flow : 10.02B for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.10B |
| Johnson & Johnson | 19.70B |
| Eli Lilly & Co. | 5.964B |
| Merck & Co., Inc. | 13.05B |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.327B |
| Cash from Investing (Quarterly) | -1.835B |
| Cash from Financing (Quarterly) | -1.263B |
| Free Cash Flow Per Share (Quarterly) | 2.655 |
| Free Cash Flow to Equity (Quarterly) | 28.27B |
| Free Cash Flow to Firm (Quarterly) | 3.595B |
| Free Cash Flow Yield | 5.28% |